Please sign in to follow a disease.
Robots take on knee surgery: a new trial for PCL fractures
NCT ID NCT07575256
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares robot-assisted arthroscopic surgery to standard open surgery for fixing a type of knee fracture called a PCL avulsion. The goal is to see if the robot helps the bone heal more accurately and improves long-term knee function. The trial will enroll 22 adults with recent fractures and follow them after surgery.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Robot-assisted arthroscopic surgery
- What this could lead to
- If successful, this could show that robot-assisted surgery leads to more precise bone alignment and better knee function recovery after a PCL avulsion fracture.
- What could go wrong
- This is a very small early study with only 22 participants, so results may not apply to everyone. The robot may not improve outcomes enough to justify its cost or complexity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 22 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age ≥ 18 years * Acute closed tibial avulsion fracture, with surgery performed within 3 weeks of injury ③ Radiographically confirmed Meyers-McKeever classification Type II or III fracture ④ Absence of absolute contraindications to surgical intervention ⑤ Provision of voluntary, written informed consent prior to enrollment Exclusion Criteria: * Pathological fractures or complex ipsilateral injuries, including concomitant fractures at other anatomical sites. * Prior ipsilateral knee joint surgery. ③. Significant vascular or neurological compromise. * Acute meniscal tears, acute anterior cruciate ligament (ACL) ruptures, or acute injuries to the medial or lateral collateral ligaments. * Compromised local soft tissue integrity, including open fractures. ⑥. Withdrawal from the study or loss to follow-up despite having provided written informed consent.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PCL - posterior cruciate ligament deficiency are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.